IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Heart failure after allogeneic hematopoietic stem cell transplantation
Mo, Xiao-Dong; Xu, Lan-Ping; Liu, Dai-Hong; Zhang, Xiao-Hui; Chen, Huan; Chen, Yu-Hong; Han, Wei; Wang, Yu; Wang, Feng-Rong; Wang, Jing-Zhi; Zhao, Ting; Yan, Chen-Hua; Sun, Yu-Qian; Liu, Kai-Yan; Huang, Xiao-Jun1
关键词Heart failure Allogeneic hematopoietic stem Transplant-related complication
刊名INTERNATIONAL JOURNAL OF CARDIOLOGY
2013-09-10
DOI10.1016/j.ijcard.2012.06.021
167期:6页:2502-2506
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Cardiac & Cardiovascular Systems
研究领域[WOS]Cardiovascular System & Cardiology
关键词[WOS]BONE-MARROW-TRANSPLANTATION ; HIGH-DOSE CYCLOPHOSPHAMIDE ; VERSUS-HOST-DISEASE ; CARDIAC COMPLICATIONS ; CHILDHOOD-CANCER ; PREDICTIVE-VALUE ; ONCOLOGY-GROUP ; ACUTE GVHD ; CARDIOTOXICITY ; THERAPY
英文摘要

Background: Heart failure (HF) occurring after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare but severe. We examine the role of pre-HSCT therapeutic exposures, conditioning regimens, pre-HSCT comorbidities, severe transplant-related complications, and post-HSCT cardiovascular risk factors in the development of heart failure after allo-HSCT.

Methods: A nested case-control study was designed. Cases with HF and controls matched for age, year of allo-HSCT, and length of follow-up were identified from a cohort of 2455 patients who underwent allo-HSCT between 2000 and 2011 for hematologic malignancies.

Results: Forty-two patients suffered from HF; mean age at presentation was 35 years (+/- 14 years) and mean time to presentation was 5 months (+/- 9 months) post-HSCT. The number of pre-HSCT cycles of chemotherapy was significantly greater (7 vs. 5 courses, P=0.023). Cases were significantly more likely to have severe acute GVHD (>= grade III), hemorrhagic cystitis (>= grade 2), and multiple severe transplant-related complications compared with controls (42.9% vs. 20.4%, P=0.008). Multivariate analysis revealed that pre-HSCT cycles of chemotherapy of >= 5 courses (OR=3.5, P=0.003) and two or more severe transplant-related complications (OR=3.6, P=0.003) were independently associated with HF.

Conclusions: These results identify the individuals who are at higher risk of developing HF after allo-HSCT. We should pay more attention to these patients and more active management would be reasonable. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

语种英语
WOS记录号WOS:000324478400035
项目编号2011AA020105 ; 30971292
资助机构National High Technology Research and Development Program of China (Program 863) ; National Natural Science Foundation of China
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58614
专题北京大学第二临床医学院
北京大学第二临床医学院_血液科
作者单位1.Peking Univ, Peoples Hosp, Beijing Key Lab Hematopoit Stem Cell Transplantat, Beijing 100044, Peoples R China
2.Inst Hematol, Beijing Key Lab Hematopoit Stem Cell Transplantat, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Mo, Xiao-Dong,Xu, Lan-Ping,Liu, Dai-Hong,et al. Heart failure after allogeneic hematopoietic stem cell transplantation[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY,2013,167(6):2502-2506.
APA Mo, Xiao-Dong.,Xu, Lan-Ping.,Liu, Dai-Hong.,Zhang, Xiao-Hui.,Chen, Huan.,...&Huang, Xiao-Jun.(2013).Heart failure after allogeneic hematopoietic stem cell transplantation.INTERNATIONAL JOURNAL OF CARDIOLOGY,167(6),2502-2506.
MLA Mo, Xiao-Dong,et al."Heart failure after allogeneic hematopoietic stem cell transplantation".INTERNATIONAL JOURNAL OF CARDIOLOGY 167.6(2013):2502-2506.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Mo, Xiao-Dong]的文章
[Xu, Lan-Ping]的文章
[Liu, Dai-Hong]的文章
百度学术
百度学术中相似的文章
[Mo, Xiao-Dong]的文章
[Xu, Lan-Ping]的文章
[Liu, Dai-Hong]的文章
必应学术
必应学术中相似的文章
[Mo, Xiao-Dong]的文章
[Xu, Lan-Ping]的文章
[Liu, Dai-Hong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。